Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
Abstract:
The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.
Information query
Patent Agency Ranking
0/0